A detailed history of Stone X Group Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Stone X Group Inc. holds 12,915 shares of ABT stock, worth $1.48 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
12,915
Previous 11,647 10.89%
Holding current value
$1.48 Million
Previous $1.21 Million 21.65%
% of portfolio
0.13%
Previous 0.12%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$100.07 - $118.13 $126,888 - $149,788
1,268 Added 10.89%
12,915 $1.47 Million
Q2 2024

Aug 07, 2024

BUY
$100.73 - $112.44 $128,531 - $143,473
1,276 Added 12.3%
11,647 $1.21 Million
Q1 2024

May 01, 2024

BUY
$109.52 - $120.96 $1.14 Million - $1.25 Million
10,371 New
10,371 $1.18 Million
Q3 2022

Nov 08, 2022

BUY
$96.76 - $112.03 $51,476 - $59,599
532 Added 10.02%
5,842 $565,000
Q2 2022

Jul 27, 2022

BUY
$102.07 - $123.37 $541,991 - $655,094
5,310 New
5,310 $577,000
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $727,333 - $886,936
-6,379 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $63,194 - $77,378
547 Added 9.38%
6,379 $898,000
Q3 2021

Oct 20, 2021

BUY
$116.66 - $129.06 $91,344 - $101,053
783 Added 15.51%
5,832 $689,000
Q2 2021

Aug 06, 2021

BUY
$105.79 - $124.53 $62,627 - $73,721
592 Added 13.28%
5,049 $585,000
Q1 2021

Jun 23, 2021

SELL
$108.84 - $128.23 $3,700 - $4,359
-34 Reduced 0.76%
4,457 $534,000
Q4 2020

Feb 03, 2021

SELL
$105.0 - $114.42 $1,785 - $1,945
-17 Reduced 0.38%
4,491 $491,000
Q3 2020

Nov 12, 2020

BUY
$91.64 - $111.29 $72,945 - $88,586
796 Added 21.44%
4,508 $490,000
Q2 2020

Aug 12, 2020

BUY
$76.57 - $98.0 $57,963 - $74,186
757 Added 25.62%
3,712 $339,000
Q1 2020

Apr 30, 2020

BUY
$62.82 - $91.86 $185,633 - $271,446
2,955 New
2,955 $233,000
Q3 2017

Nov 13, 2017

SELL
$48.06 - $53.64 $205,023 - $228,828
-4,266 Closed
0 $0
Q2 2017

Aug 31, 2017

BUY
N/A
4,266
4,266 $207,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.